Adhera Therapeutics, Inc. (f/k/a Marina Biotech, Inc.)
Why this matters
The content provided is only a title and a note indicating an RSS summary. There is no substantive regulatory information, guidance, enforcement action, or policy statement. The item appears to be a routine corporate filing notification from the SEC with no specific regulatory significance beyond administrative record-keeping.
AI-generated classification rationale, not a full analysis. Verify with the original SEC source before acting. Full disclaimer.
What the SEC said
Adhera Therapeutics, Inc. (f/k/a Marina Biotech, Inc.)
Published by SEC . Read the full notice at the source for the authoritative text.
Context
Securities and Exchange Commission (SEC) — Primary regulator of US securities markets. We track 295 updates from them.
US financial regulation is overseen by multiple agencies including the SEC, CFTC, Federal Reserve, OCC and FDIC. Browse all United States updates.